Relationship of acquired resistance of myeloma cells to bortezomib with Lyn and Src induced inhibition of PP2A and effect of treatment with the tyrosine kinase inhibitor dasatinib.

Conference Paper

Full Text

Published version (via Digital Object Identifier)

Duke Authors

Cited Authors

Paul, B; Feinberg, D; Sundaramoorthy, P; Weinberg, JB; Kang, Y

Published Date

May 20, 2018

Published In

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Volume / Issue

36 / 15_suppl

Start / End Page

8047 - 8047

Published By

American Society of Clinical Oncology (ASCO)

Electronic International Standard Serial Number (EISSN)

1527-7755

International Standard Serial Number (ISSN)

0732-183X

Digital Object Identifier (DOI)

10.1200/jco.2018.36.15_suppl.8047